The Third Age of Antimicrobial Therapy
Open Access
- 15 May 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (10) , 1414-1416
- https://doi.org/10.1086/503431
Abstract
Potential conflicts of interest. A.C.: no conflicts.Keywords
This publication has 16 references indexed in Scilit:
- A Randomized, Blinded, Multicenter Trial of Lipid-Associated Amphotericin B Alone versus in Combination with an Antibody-Based Inhibitor of Heat Shock Protein 90 in Patients with Invasive CandidiasisClinical Infectious Diseases, 2006
- Anti-infective monoclonal antibodies: perils and promise of developmentNature Reviews Drug Discovery, 2006
- A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy VolunteersClinical Infectious Diseases, 2005
- Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal MeningitisThe Journal of Infectious Diseases, 2004
- Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90Antimicrobial Agents and Chemotherapy, 2003
- Adjunctive Immune Therapy for Fungal InfectionsClinical Infectious Diseases, 2001
- Crisis in Infectious Diseases: Time for a New Paradigm?Clinical Infectious Diseases, 1996
- Return to the Past: The Case for Antibody-Based Therapies in Infectious DiseasesClinical Infectious Diseases, 1995
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- ANTIMICROBIAL CHEMOTHERAPYAnnual Review of Microbiology, 1956